Bial to Market in Europe Sublingual Film for ‘Off’ Periods, If Approved

Bial to Market in Europe Sublingual Film for ‘Off’ Periods, If Approved

305112

Bial to Market in Europe Sublingual Film for ‘Off’ Periods, If Approved

Bial has entered into an exclusive agreement to market upon approval in Europe APL-130277 — Sunovion Pharmaceuticals‘ sublingual (under the tongue) film of apomorphine for off episodes in Parkinson’s disease. Under the agreement’s terms, Bial will be responsible for preparing a marketing authorization application for regulatory agencies there — drawing on data that includes Phase 3 trials in Europe — which the company expects to submit by the end of the year, a press release stated. Should the European Commission…

You must be logged in to read/download the full post.